InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: DesireToLearn post# 200179

Monday, 10/16/2017 1:44:15 PM

Monday, October 16, 2017 1:44:15 PM

Post# of 403036
I agree with your post. That is why I started discussions this weekend on competition for B-OM. There are many sides to every story and it is truly ignorant to only see one.

I will say; that the company has not responded to me for some time now and that is unusual. I have a feeling they are extremely busy and the tension between all of their CDA's and potential partners have them sitting with a heavy lid on any communication. As Leo has been saying all year. 2017's focus is on partnerships and he knew they would have the phase 2 data sets to achieve that goal.

I recommend everyone look at SOX's sticky post on trial progression. For all the people that post FUD here, that is as clear it can be on how lean and mean this company is. To move along that many trials in 5 years and only add 40-50 million in OS is very respectable.
Note - in 2012 there was zero cash on hand, no financial agreements and the stock price was higher than it was today with the K phase 1 just starting and the only human clinical trial.

GO IPIX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News